– Global, pivotal Phase 3 study will evaluate efficacy and safety of zorevunersen compared to sham over a 52-week treatment…
• First Patient Dosing Expected in Q1 2026 • Clinical Trial to Prioritize Biomarker-Selected RBM39-Dependent Cancers KING OF PRUSSIA, Pa., Aug.…
MIAMI, FL / ACCESS Newswire / August 9, 2025 / When we first heard about Sleep Lean, our expectations were…
First-of-its-kind partnership between InterContinental Singapore and NuCalm brings cutting edge restorative travel to luxury travelers LOS ANGELES, Aug. 8, 2025 /PRNewswire/…
CHICAGO, IL / ACCESS Newswire / August 8, 2025 / If that constant ringing in your ears is starting to…
The Brain Computer Interface (BCI) market is experiencing rapid growth due to increasing advancements in neurotechnology, rising demand for assistive…
MINNEAPOLIS, Aug. 7, 2025 /PRNewswire/ -- An individual born in 2025 is projected to spend 21 years of their life—equivalent…
Developed by world-renowned neuroscientist Professor Adrian Owen, Creyos helps providers detect cognitive impairment through a scientifically validated brain health assessment platform…
New data from Eurofins Discovery show that Telomir-1 blocks enzymes that drive disease by turning off critical genes-highlighting its potential…
THE HAGUE, Netherlands, Aug. 7, 2025 /PRNewswire/ -- Over 1.2 million internet-connected healthcare devices and systems with exposure that endanger patient…